Mushrooms Becoming a Popular Way to Strengthen Your Immune System

March 26, 2020 - By: Baystreet Staff


Mushrooms are proving to be magic for your immune system.

Researchers form Griffith University, notes The New Daily, have said it’s well documented that mushrooms have the “ability to activate cell immunity in humans. They do this through their possession of beta-glucans, which humans don’t have. So, when human cells come into contact with this foreign body, the immune system starts to fire up and respond.”

Reportedly, mushrooms such as Reishi can help with sleep, anxiety, and depression. Lion’s mane can help with memory and concentration. Chaga can help with inflammation for example. Turkey tail can help support the immune system, and assist with cancer prevention.

Even more exciting, studies have already shown that when mushrooms are “ingested it transforms into a psychoactive chemical in the body that might help dramatically reduce symptoms of depression, messing with the brain's pre-frontal cortex, which affects our mood and perception of things and another part of your brain, that’s a part of processing emotional reaction to fear and anxiety,” as reported by Spectrum News.

As the health benefits are realized, it’s opening a range of opportunity for companies that have already established launching cannabis products including The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF), The Green Organic Dutchman (TO:TGOD)(OTC:TGODF), Canopy Growth Corporation (TO:WEED)(NYSE:CGC), The Supreme Cannabis Company Inc. (TO:FIRE)(OTC:SPRWF), and OrganiGram Holdings Inc. (NASDAQ:OGI)(TSXV:OGI).

The Yield Growth Corp. (CSE:BOSS)(OTCQB:BOSQF) BREAKING NEWS: The Yield Growth Corp. subsidiary Flourish Mushroom Labs is pleased to announce that it has entered into a manufacturing agreement with Canadian Phytopharmaceuticals Corp. to begin production of its Ayurvedic mushroom coffee line.

“Our Ayurvedic mushroom coffees are formulated with immune-boosting medicinal mushrooms that are antioxidant and nutrient-rich. This includes reishi, chaga, lion's mane and turkey tail mushrooms, all of which are widely regarded for their health benefits,” said Penny White, CEO of Flourish Mushroom Labs. “This is especially top of mind in the midst of the global health crisis we are currently facing. For us, it is crucial that we are able to deliver health-boosting products that are easy to consume and delicious as we all try to keep ourselves and our families healthy.”

Canadian Phytopharmaceuticals Corporation is a GMP (Good Manufacturing Practices) certified contract manufacturer and private labeller with more than twenty years experience.

“Our new manufacturing partner is recognized for its dedication to research, innovation and the development and manufacturing of top quality botanical extracts, natural health products and dietary supplements,” added White.

The Ayurvedic mushroom coffees are planned for launch in the summer of 2020.

The global market for functional mushrooms is forecasted to reach $34 billion by 2024 and grow at a CAGR of 8% between 2019 and 2024, according to a report from Mordor Intelligence.

Functional foods using mushrooms and Ayurvedic botanicals have a long history of therapeutic use. According to Health Canada, a functional food is demonstrated to have physiological benefits and/or reduce the risk of chronic disease beyond basic nutritional functions.

“The mushrooms we have chosen are nutrient-dense superfoods that are loaded with a wide range of impressive health benefits,” said Bhavna Solecki, Director of Product Development for The Yield Growth Corp. “Chaga is a known stress-adaptogen and immune modulator to stimulate and regulate the immune system. Reishi has immunostimulatory effects and shows antiviral activity. Turkey tail effectively strengthens the immune system and prevents colds and influenza while lion's mane reduces anxiety and depression and improves cognitive function.”

The products are also planned to contain other Ayurvedic botanical ingredients such as Holy Basil, which naturally decreases anxiety; moringa, which acts as an antiviral and antidepressant; gotu kola, which reduces anxiety and stress while improving circulation, and amla; a potent fighter against bacteria and viruses.

“Our immune system is evolving and continuously fighting illnesses and environmental toxins. In these unpredictable times it is kindness, caring and being responsible for what we put in our bodies, our health and the health of our loved ones that will see us through," said White.

Other related developments from around the markets include:

The Green Organic Dutchman (TO:TGOD)(OTC:TGODF) reports its results for the fourth quarter and fiscal year ended December 31, 2019. “While 2019 was a challenging year for the entire sector, we have made significant progress on the operational front and adjusted our construction and operating plan to preserve shareholder capital and in light of changing market conditions,” commented Brian Athaide, CEO of TGOD. “Despite taking impairment charges this quarter, as we continue to evaluate financing options, we note that the value of our assets still far exceeds our liabilities. With our first 2.0 product, TGOD Infusers, now available, our teas and vapes launching next month, as well as additional launches planned later this year, we anticipate continued sales momentum for the rest of 2020,” continued Athaide.

Canopy Growth Corporation (TO:WEED)(NYSE:CGC) announced that the Company plans to close its facilities in Aldergrove and Delta, British Columbia, resulting in the elimination of approximately 500 positions. In addition, the Company no longer plans to bring a third greenhouse online in Niagara-on-the-Lake, Ontario. These actions are part of the Company’s effort to align supply and demand while improving production efficiencies over time. The greenhouses in B.C. account for approximately 3 million square feet of licensed production space and were put into commission, beginning in February 2018, after a period of phased retrofitting to help Canopy Growth scale up to supply the new Canadian adult-use market.  Nearly 17 months after the creation of the legal adult-use market, the Canadian recreational market has developed slower than anticipated, creating working capital and profitability challenges across the industry.  Additionally, federal regulations permitting outdoor cultivation were introduced after the Company made significant investments in greenhouse production. The Company now operates an outdoor production site  to allow for more cost-effective cultivation which will play an  important role in meeting demand on certain products that rely on cannabis extracts.  Following an organizational strategic review of production capacity and forecasted demand, the Company announced today that these facilities in Aldergrove and Delta, British Columbia are no longer essential to its cultivation footprint.

The Supreme Cannabis Company Inc. (TO:FIRE)(OTC:SPRWF) announced its financial and operating results for the three and six months ended December 31, 2019, as well as an update on its strategy and outlook. As announced on February 11, 2020, Supreme Cannabis has implemented a new operating structure, including staff reductions, to drive efficiencies and support long-term, profitable growth. With an optimized cost structure in place, the Company is moving forward with its strategy to transition to a premium cannabis CPG company, driving near-term revenue with new high-quality brands and products at every price segment. This expanded, consumer-facing brand portfolio is being supported by an innovative sales model that achieves comprehensive distribution across Canada. “As we realign our structure and expectations with the current state of the industry, I maintain my strong belief in Supreme Cannabis’ ability to drive near-term revenue growth, profitability and long-term value with new high-quality brands and products at every key price segment,” said Colin Moore, Director and Interim President and CEO. “I’m proud of the team’s progress and difficult work rightsizing the Company’s cost structure and focusing the business on near-term revenue drivers. As one of the few licensed producers with completed cultivation infrastructure and in-house value-added processing capabilities, as well as proven premium brands in the recreational market, we are well positioned to accelerate our CPG-focused transition. Our strong liquidity position, including the Credit Facility arranged by a tier one bank, further ensures we have the capital necessary to execute going forward.”

OrganiGram Holdings Inc. (NASDAQ:OGI)(TSXV:OGI) announced that Paolo De Luca, the Company’s current Chief Financial Officer has been appointed Chief Strategy Officer and Derrick West, currently on the Company’s Board of Directors, is joining the Company as its CFO. “In this highly dynamic and growing industry, we are strengthening the skill and scope of our leadership team," said Greg Engel, Chief Executive Officer. “I am thrilled to have Paolo take on the role of Chief Strategy Officer. He has been intimately involved in our strategy development since he joined Organigram and has an excellent track record of rapidly and profitably scaling the Company through substantial growth. This dedicated role will allow him to resolutely focus on the ongoing evolution and execution of strategy critical to our continued success. At the same time, our leadership team is benefiting from the appointment of Derrick West, an experienced finance and accounting professional with strong knowledge of Organigram and the industry after serving on the Board of Directors, including as Chair of the Audit Committee, over the last two years.”

Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media which has a partnership with www.MarijuanaStox.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. Winning Media, which has a partnership with www.MarijuanaStox.com, is only compensated for its services in the form of cash-based compensation. Pursuant to an agreement between Winning Media (partners of www.MarijuanaStox.com) and The Yield Growth Corp., Winning Media has been paid three thousand five hundred dollars for advertising and marketing services for The Yield Growth Corp. We own ZERO shares of The Yield Growth Corp. Please click here for full disclaimer.

Contact Information:
2818047972
ty@MarijuanaStox.com

News & Analysis